Martin F. Schacker
Director Ejecutivo en Tetragenex Pharmaceuticals, Inc. .
Cargos activos de Martin F. Schacker
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Tetragenex Pharmaceuticals, Inc.
 Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Director Ejecutivo | 05/02/2010 | - |
| Presidente | 05/02/2010 | - |
Historial de carrera de Martin F. Schacker
Antiguos cargos conocidos de Martin F. Schacker.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| M.S. Farrell & Co., Inc. | Presidente | 02/02/2001 | 02/02/2001 |
| Presidente | - | 02/02/2001 | |
| D.H. Blair & Co. | Corporate Officer/Principal | 02/12/1991 | 02/12/1991 |
Lehman Brothers Holdings Plc
 Lehman Brothers Holdings Plc Investment Banks/BrokersFinance Lehman Brothers Holdings Plc provides finance and treasury management services. The company is headquartered in London, UK. | Corporate Officer/Principal | 02/05/1987 | 02/05/1987 |
Formación de Martin F. Schacker.
| Hofstra University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Reino Unido | 2 |
Operativa
| Chairman | 2 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
Sectorial
| Health Technology | 2 |
| Finance | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Tetragenex Pharmaceuticals, Inc.
Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Health Technology |
| M.S. Farrell & Co., Inc. | |
| D.H. Blair & Co. | |
Lehman Brothers Holdings Plc
Lehman Brothers Holdings Plc Investment Banks/BrokersFinance Lehman Brothers Holdings Plc provides finance and treasury management services. The company is headquartered in London, UK. | Finance |
- Bolsa de valores
- Insiders
- Martin F. Schacker
- Experiencia
